Bhadresh Vyas
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Bhadresh Vyas has a total of 89 co-authors. Here are the top co-authors by number of shared publications:
- Anupama Machathi
Department of Community Medicine, Christian Medical College, Vellore, Tamil Nadu, India
2 shared publications - Manoja Kumar Das
Kathmandu University
2 shared publications - Namrata Kharat
Department of Community Medicine, Christian Medical College, Vellore, Tamil Nadu, India
2 shared publications - Niket Patel
Department of Pediatrics, M. P. Shah Government Medical College, Jamnagar, India
2 shared publications - Pankaj Buch
Department of Pediatrics, Pandit Dindayal Upadhyay (PDU) Medical College, Rajkot, India
2 shared publications - Ragavi Lingam
Department of Community Medicine, Christian Medical College, Vellore, India
2 shared publications
Latest Publications
- Open Access
- 11 November 2025
- Published by Springer Nature in Indian Journal of Pediatrics
- Vol. 92 (S1) , 88-93
Epidemiology and Management of Intussusception Among Children Aged Under 2 Years in Gujarat, India
Objectives Some rotavirus vaccines are associated with an increased risk of intussusception (IS) in children. This study investigated the epidemiology of IS in children aged under 2 y in Gujarat, India. Methods Hospital-based surveillance of IS cases was conducted from July 2019 to December 2022 at four hospitals in Gujarat. Children aged under 2 y who met the level 1 Brighton criteria were enrolled. Data were collected on their sociodemographic and clinical characteristics, clinical management, feeding patterns, and immunization history. Results Overall, 213 children with IS were enrolled. Their median age was 8 (interquartile range, 6–13) mo and 62.9% were boys. No seasonal variation in the incidence of IS was observed. The most common presenting complaints were vomiting (82.6%), abdominal pain (76.1%), and bloody stools (53%). Most cases (56.3%) were managed via radiological reduction; 21.6% underwent exploratory laparotomy and intra-operative reduction; 10.3% underwent bowel resection; and 11.7% were treated using mixed modalities. Children admitted more than 48 h after the onset were significantly more likely to require surgical intervention (33% vs. 17.9%, p = 0.002) and have hospital stays > 5 d (59% vs. 35.2%, p < 0.001). In total, 13 of 169 children with documented rotavirus vaccination had received a dose of rotavirus vaccine within 21 d of the onset of symptoms. Conclusions Ongoing surveillance is needed to establish whether vaccination with the oral pentavalent rotavirus vaccine, ROTASIIL, is associated with an increased risk of IS. Early case detection and referral, and increased use of safe and non-surgical methods of treatment need to be encouraged.
- 11 November 2025
- Published by Springer Nature in Indian Journal of Pediatrics
- Vol. 92 (S1) , 88-93
Open AccessEpidemiology and Management of Intussusception Among Children Aged Under 2 Years in Gujarat, India
Objectives Some rotavirus vaccines are associated with an increased risk of intussusception (IS) in children. This study investigated the epidemiology of IS in children aged under 2 y in Gujarat, India. Methods Hospital-based surveillance of IS cases was conducted from July 2019 to December 2022 at four hospitals in Gujarat. Children aged under 2 y who met the level 1 Brighton criteria were enrolled. Data were collected on their sociodemographic and clinical characteristics, clinical management, feeding patterns, and immunization history. Results Overall, 213 children with IS were enrolled. Their median age was 8 (interquartile range, 6–13) mo and 62.9% were boys. No seasonal variation in the incidence of IS was observed. The most common presenting complaints were vomiting (82.6%), abdominal pain (76.1%), and bloody stools (53%). Most cases (56.3%) were managed via radiological reduction; 21.6% underwent exploratory laparotomy and intra-operative reduction; 10.3% underwent bowel resection; and 11.7% were treated using mixed modalities. Children admitted more than 48 h after the onset were significantly more likely to require surgical intervention (33% vs. 17.9%, p = 0.002) and have hospital stays > 5 d (59% vs. 35.2%, p < 0.001). In total, 13 of 169 children with documented rotavirus vaccination had received a dose of rotavirus vaccine within 21 d of the onset of symptoms. Conclusions Ongoing surveillance is needed to establish whether vaccination with the oral pentavalent rotavirus vaccine, ROTASIIL, is associated with an increased risk of IS. Early case detection and referral, and increased use of safe and non-surgical methods of treatment need to be encouraged.
- 7 November 2025
- Published by Springer Nature in Indian Journal of Pediatrics
- Vol. 92 (S1) , 62-67
Epidemiology and Burden of Rotavirus-Associated Acute Gastroenteritis Among Children Aged Under 5 Years in Gujarat, India, from 2020 to 2023
Objectives Rotavirus is a common cause of severe acute gastroenteritis (AGE) in children aged under 5 y, worldwide and in India. In this study, the authors describe the epidemiology and burden of rotavirus AGE (RVAGE) among children aged under 5 y in Gujarat, India, from 2020 to 2023, to determine the prevalence of rotavirus infection and to describe the seasonal and genotype patterns and clinical characteristics of RVAGE. Methods A prospective, hospital-based surveillance was conducted at four tertiary-care government hospitals in Gujarat. Children aged under 5 y admitted with AGE were enrolled, and their clinical, demographic, and vaccination data were collected. All stool samples positive for rotavirus on enzyme-linked immunosorbent assay (ELISA) were genotyped using reverse-transcription polymerase chain reaction. Results Of the 1,220 children enrolled, 1,156 (94.8%) had adequate stool samples for ELISA. The overall rotavirus positivity was 17.9% and was highest in children aged 12–23 mo (22.2%). Rotavirus positivity peaked between November and February. Compared with rotavirus-negative participants, children with RVAGE had a significantly higher likelihood of experiencing vomiting (odds ratio [OR]: 1.99, 95% confidence interval [CI]: 1.41–2.81) and severe to very severe diarrhea (OR: 1.91, 95% CI: 1.37–2.67). The most prevalent rotavirus genotypes were G3P[8] (43.6%) and G2P[4] (30.5%). Conclusions RVAGE is a substantial burden among children aged under 5 y in Gujarat, India, particularly among infants and toddlers. This study highlights the importance of continued rotavirus surveillance and the requirement of widespread vaccination to reduce morbidity and mortality associated with RVAGE in this population.
- 7 November 2025
- Published by Springer Nature in Indian Journal of Pediatrics
- Vol. 92 (S1) , 62-67
Epidemiology and Burden of Rotavirus-Associated Acute Gastroenteritis Among Children Aged Under 5 Years in Gujarat, India, from 2020 to 2023
Objectives Rotavirus is a common cause of severe acute gastroenteritis (AGE) in children aged under 5 y, worldwide and in India. In this study, the authors describe the epidemiology and burden of rotavirus AGE (RVAGE) among children aged under 5 y in Gujarat, India, from 2020 to 2023, to determine the prevalence of rotavirus infection and to describe the seasonal and genotype patterns and clinical characteristics of RVAGE. Methods A prospective, hospital-based surveillance was conducted at four tertiary-care government hospitals in Gujarat. Children aged under 5 y admitted with AGE were enrolled, and their clinical, demographic, and vaccination data were collected. All stool samples positive for rotavirus on enzyme-linked immunosorbent assay (ELISA) were genotyped using reverse-transcription polymerase chain reaction. Results Of the 1,220 children enrolled, 1,156 (94.8%) had adequate stool samples for ELISA. The overall rotavirus positivity was 17.9% and was highest in children aged 12–23 mo (22.2%). Rotavirus positivity peaked between November and February. Compared with rotavirus-negative participants, children with RVAGE had a significantly higher likelihood of experiencing vomiting (odds ratio [OR]: 1.99, 95% confidence interval [CI]: 1.41–2.81) and severe to very severe diarrhea (OR: 1.91, 95% CI: 1.37–2.67). The most prevalent rotavirus genotypes were G3P[8] (43.6%) and G2P[4] (30.5%). Conclusions RVAGE is a substantial burden among children aged under 5 y in Gujarat, India, particularly among infants and toddlers. This study highlights the importance of continued rotavirus surveillance and the requirement of widespread vaccination to reduce morbidity and mortality associated with RVAGE in this population.
- Top Cited PapersOpen Access
- 24 July 2018
- Published by Public Library of Science (PLoS) in PLOS Medicine
- Vol. 15 (7) , e1002615
Neurodevelopmental disorders in children aged 2–9 years: Population-based burden estimates across five regions in India
Neurodevelopmental disorders (NDDs) compromise the development and attainment of full social and economic potential at individual, family, community, and country levels. Paucity of data on NDDs slows down policy and programmatic action in most developing countries despite perceived high burden. We assessed 3,964 children (with almost equal number of boys and girls distributed in 2–N = 998; all rural, 16.4% non-Hindu, 25.3% from scheduled caste/tribe [SC-ST] [these are considered underserved communities who are eligible for affirmative action]); North, i.e., Kangra (N = 997; 91.6% rural, 3.7% non-Hindu, 25.3% SC-ST); East, i.e., Dhenkanal (N = 981; 89.8% rural, 1.2% non-Hindu, 38.0% SC-ST); South, i.e., Hyderabad (N = 495; all urban, 25.7% non-Hindu, 27.3% SC-ST) and West, i.e., North Goa (N = 493; 68.0% rural, 11.4% non-Hindu, 18.5% SC-ST). All children were assessed for vision impairment (VI), epilepsy (Epi), neuromotor impairments including cerebral palsy (NMI-CP), hearing impairment (HI), speech and language disorders, autism spectrum disorders (ASDs), and intellectual disability (ID). Furthermore, 6–9-year-old children were also assessed for attention deficit hyperactivity disorder (ADHD) and learning disorders (LDs). We standardized sample characteristics as per Census of India 2011 to arrive at district level and all-sites-pooled estimates. Site-specific prevalence of any of seven NDDs in 2–<6 year olds ranged from 2.9% (95% CI 1.6–5.5) to 18.7% (95% CI 14.7–23.6), and for any of nine NDDs in the 6–9-year-old children, from 6.5% (95% CI 4.6–9.1) to 18.5% (95% CI 15.3–22.3). Two or more NDDs were present in 0.4% (95% CI 0.1–1.7) to 4.3% (95% CI 2.2–8.2) in the younger age category and 0.7% (95% CI 0.2–2.0) to 5.3% (95% CI 3.3–8.2) in the older age category. All-site-pooled estimates for NDDs were 9.2% (95% CI 7.5–11.2) and 13.6% (95% CI 11.3–16.2) in children of 2–<6 and 6–9 year age categories, respectively, without significant difference according to gender, rural/urban residence, or religion; almost one-fifth of these children had more than one NDD. The pooled estimates for prevalence increased by up to three percentage points when these were adjusted for national rates of stunting or low birth weight (LBW). HI, ID, speech and language disorders, Epi, and LDs were the common NDDs across sites. Upon risk modelling, noninstitutional delivery, history of perinatal asphyxia, neonatal illness, postnatal neurological/brain infections, stunting, LBW/prematurity, and older age category (6–9 year) were significantly associated with NDDs. The study sample was underrepresentative of stunting and LBW and had a 15.6% refusal. These factors could be contributing to underestimation of the true NDD burden in our population. The study identifies NDDs in children aged 2–9 years as a significant public health burden for India. HI was higher than and ASD prevalence comparable to the published global literature. Most risk factors of NDDs were modifiable and amenable to public health interventions.
- 24 July 2018
- Published by Public Library of Science (PLoS) in PLOS Medicine
- Vol. 15 (7) , e1002615
Top Cited PapersOpen AccessNeurodevelopmental disorders in children aged 2–9 years: Population-based burden estimates across five regions in India
Neurodevelopmental disorders (NDDs) compromise the development and attainment of full social and economic potential at individual, family, community, and country levels. Paucity of data on NDDs slows down policy and programmatic action in most developing countries despite perceived high burden. We assessed 3,964 children (with almost equal number of boys and girls distributed in 2–N = 998; all rural, 16.4% non-Hindu, 25.3% from scheduled caste/tribe [SC-ST] [these are considered underserved communities who are eligible for affirmative action]); North, i.e., Kangra (N = 997; 91.6% rural, 3.7% non-Hindu, 25.3% SC-ST); East, i.e., Dhenkanal (N = 981; 89.8% rural, 1.2% non-Hindu, 38.0% SC-ST); South, i.e., Hyderabad (N = 495; all urban, 25.7% non-Hindu, 27.3% SC-ST) and West, i.e., North Goa (N = 493; 68.0% rural, 11.4% non-Hindu, 18.5% SC-ST). All children were assessed for vision impairment (VI), epilepsy (Epi), neuromotor impairments including cerebral palsy (NMI-CP), hearing impairment (HI), speech and language disorders, autism spectrum disorders (ASDs), and intellectual disability (ID). Furthermore, 6–9-year-old children were also assessed for attention deficit hyperactivity disorder (ADHD) and learning disorders (LDs). We standardized sample characteristics as per Census of India 2011 to arrive at district level and all-sites-pooled estimates. Site-specific prevalence of any of seven NDDs in 2–<6 year olds ranged from 2.9% (95% CI 1.6–5.5) to 18.7% (95% CI 14.7–23.6), and for any of nine NDDs in the 6–9-year-old children, from 6.5% (95% CI 4.6–9.1) to 18.5% (95% CI 15.3–22.3). Two or more NDDs were present in 0.4% (95% CI 0.1–1.7) to 4.3% (95% CI 2.2–8.2) in the younger age category and 0.7% (95% CI 0.2–2.0) to 5.3% (95% CI 3.3–8.2) in the older age category. All-site-pooled estimates for NDDs were 9.2% (95% CI 7.5–11.2) and 13.6% (95% CI 11.3–16.2) in children of 2–<6 and 6–9 year age categories, respectively, without significant difference according to gender, rural/urban residence, or religion; almost one-fifth of these children had more than one NDD. The pooled estimates for prevalence increased by up to three percentage points when these were adjusted for national rates of stunting or low birth weight (LBW). HI, ID, speech and language disorders, Epi, and LDs were the common NDDs across sites. Upon risk modelling, noninstitutional delivery, history of perinatal asphyxia, neonatal illness, postnatal neurological/brain infections, stunting, LBW/prematurity, and older age category (6–9 year) were significantly associated with NDDs. The study sample was underrepresentative of stunting and LBW and had a 15.6% refusal. These factors could be contributing to underestimation of the true NDD burden in our population. The study identifies NDDs in children aged 2–9 years as a significant public health burden for India. HI was higher than and ASD prevalence comparable to the published global literature. Most risk factors of NDDs were modifiable and amenable to public health interventions.